Cargando…
Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine
Colorectal cancer is the third most common and the fourth most lethal cancer worldwide. In most of cases, patients are diagnosed at an advanced or even metastatic stage, thus explaining the high mortality. The lack of proper clinical tests and the complicated procedures currently used for detecting...
Autores principales: | Chauvin, Anaïs, Boisvert, François-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313903/ https://www.ncbi.nlm.nih.gov/pubmed/30513835 http://dx.doi.org/10.3390/proteomes6040049 |
Ejemplares similares
-
The Promise and the Hype of ‘Personalised Medicine’
por: Maughan, Tim
Publicado: (2017) -
Personalised Medicine and the Economy of Biotechnological Promise
por: Sturdy, Steve
Publicado: (2017) -
Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015) -
The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2021) -
Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
por: Chauvin, Anaïs, et al.
Publicado: (2022)